mTOR inhibitors in pediatric liver transplant recipients

ConclusionOur results suggest that mTORi can be used in pediatric LT recipients in different clinical situations, both to reinforce immunosuppressive therapy, and to reduce CNI and related toxicity.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research